Abstract
A 58-year-old man with end-stage retinitis pigmentosa (RP) and visual acuity of light perception in both eyes received simultaneous phacoemulsification with intraocular lens implantation and implantation of the Argus II Retinal Prosthesis System (Second Sight Medical Products, Sylmar, CA) to his right eye 1 year ago. He accomplished the fitting and rehabilitation sessions, and no extraocular or intraocular complications were encountered perioperatively, postoperatively, or during the follow-up. The patient used the prosthesis actively for 2.5 to 3 hours per day. In this report, the authors compare the multimodal imaging findings including optical coherence tomography angiography of the chronic electrically stimulated retinal prosthesis implanted eye with the fellow eye.
[Ophthalmic Surg Lasers Imaging Retina. 2018;49:55–59.]
- 1.Humayun MS, Dorn JD, da Cruz L, Argus II Study Group. Interim results from the international trial of Second Sight's visual prosthesis. Ophthalmology. 2012; 119(4):779–788.
10.1016/j.ophtha.2011.09.028 Crossref Medline, Google Scholar - 2.Spaide RF, Klancnik JM, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015; 133(1):45–50.
10.1001/jamaophthalmol.2014.3616 Crossref Medline, Google Scholar - 3.Güven D, Weiland JD, Fujii G, Long-term stimulation by active epiretinal implants in normal and RCD1 dogs. J Neural Eng. 2005; 2(1):S65–73.
10.1088/1741-2560/2/1/009 Crossref Medline, Google Scholar - 4.Eng JG, Agrawal RN, Tozer KR, Morphometric analysis of optic nerves and retina from an end-stage retinitis pigmentosa patient with an implanted active epiretinal array. Invest Ophthalmol Vis Sci. 2011; 52(7):4610–4616.
10.1167/iovs.09-4936 Crossref Medline, Google Scholar - 5.Rizzo S, Belting C, Cinelli L, The Argus II Retinal Prosthesis: 12-month outcomes from a single-study center. Am J Ophthalmol. 2014; 157(6):1282–1290.
10.1016/j.ajo.2014.02.039 Crossref Medline, Google Scholar - 6.Parmeggiani F, De Nadai K, Piovan A, Binotto A, Zamengo S, Chizzolini M. Optical coherence tomography imaging in the management of the Argus II retinal prosthesis system. Eur J Ophthalmol. 2017; 27(1):e16–e21.
10.5301/ejo.5000852 Crossref Medline, Google Scholar - 7.Ahuja AK, Yeoh J, Dorn JD, Factors affecting perceptual threshold in Argus II retinal prosthesis subjects. Transl Vis Sci Technol. 2013; 2(4):1.
10.1167/tvst.2.4.1 Crossref Medline, Google Scholar - 8.Yue L, Falabella P, Christopher P, Ten-year follow-up of a blind patient chronically implanted with epiretinal prosthesis Argus I. Ophthalmology. 2015; 122(12):2545–2552.e1.
10.1016/j.ophtha.2015.08.008 Crossref Medline, Google Scholar - 9.Rachitskaya AV, Yuan A, Marino MJ, Reese J, Ehlers JP. Intraoperative OCT imaging of the Argus II Retinal Prosthesis System. Ophthalmic Surg Lasers Imaging Retina. 2016; 47(11):999–1003.
10.3928/23258160-20161031-03 Link, Google Scholar - 10.Battaglia Parodi M, Cicinelli MV, Rabiolo A, Vessel density analysis in patients with retinitis pigmentosa by means of optical coherence tomography angiography. Br J Ophthalmol. 2017; 101(4):428–432.
10.1136/bjophthalmol-2016-308925 Crossref Medline, Google Scholar - 11.Toto L, Borrelli E, Mastropasqua R, Macular features in retinitis pigmentosa: Correlations among ganglion cell complex thickness, capillary density, and macular function. Invest Ophthalmol Vis Sci. 2016; 57(14):6360–6366.
10.1167/iovs.16-20544 Crossref Medline, Google Scholar
